Niederman, Michael S.

Publications

Sort by

Co-Author Network

selected publications

Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trial. EBioMedicine. 2026 Academic Article GET IT
Times cited: 1
Severe community-acquired pneumonia: current concepts and controversies. Intensive care medicine. 2026 Information Resource GET IT
Times cited: 3
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae. Current opinion in infectious diseases. 2024 Information Resource GET IT
Times cited: 2
Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial. International journal of antimicrobial agents. 2024 Academic Article GET IT
Times cited: 8
Aspiration Pneumonia: Preface. Seminars in respiratory and critical care medicine. 2024 Academic Article GET IT
Therapy of Aspiration: Out-of-Hospital and In-Hospital-Acquired. Seminars in respiratory and critical care medicine. 2024 Information Resource GET IT
What every intensivist should know about..Patient safety huddles in the ICU. Journal of critical care. 2024 Academic Article GET IT
Community-acquired pneumonia: the best candidates for clarithromycin - Authors' reply. The Lancet. Respiratory medicine. 2024 Article GET IT
Aspiration Pneumonia. Seminars in respiratory and critical care medicine. 2024 Academic Article GET IT
Times cited: 10
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. The Lancet. Respiratory medicine. 2024 Academic Article GET IT
Times cited: 48
Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive care medicine. 2023 Article GET IT
Times cited: 5
Letter from the United States: An update on the New York experience with COVID-19. Respirology (Carlton, Vic.). 2023 Article GET IT
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive care medicine. 2023 Academic Article GET IT
Times cited: 235
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. The European respiratory journal. 2023 Academic Article GET IT
Times cited: 235
Management of pneumonia in the critically ill. Minerva medica. 2023 Academic Article GET IT
Times cited: 5
Severe community-acquired pneumonia. European respiratory review : an official journal of the European Respiratory Society. 2022 Information Resource GET IT
Times cited: 87
Respiratory infections. European respiratory review : an official journal of the European Respiratory Society. 2022 Editorial Article GET IT
Times cited: 52
What COVID-19 Has Taught Us: Ventilator-associated Pneumonia Is Back!. American journal of respiratory and critical care medicine. 2022 Editorial Article GET IT
Times cited: 2
Ventilator-associated pneumonia. Intensive care medicine. 2022 Editorial Article GET IT
Times cited: 23
Aspiration pneumonia. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2022 Information Resource GET IT
Times cited: 46
Risk Factors and Algorithms for the Empirical Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. Seminars in respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 2
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies. The journal of allergy and clinical immunology. In practice. 2021 Academic Article GET IT
Times cited: 27
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study. Critical care (London, England). 2021 Academic Article GET IT
Times cited: 28
Management of pneumonia in critically ill patients. BMJ (Clinical research ed.). 2021 Information Resource GET IT
Times cited: 137
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method. The Lancet. Infectious diseases. 2021 Information Resource GET IT
Times cited: 20
Consensus (Convergence of Opinion on Recommendations and Evidence [CORE]) Versus Systematic (Grading of Recommendations Assessment, Development, and Evaluation [GRADE]) Approach to Development of Guidelines for Community-acquired Pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Editorial Article GET IT
Too Much or Too Little Empiric Treatment for Pseudomonas aeruginosa in Community-acquired Pneumonia?. Annals of the American Thoracic Society. 2021 Editorial Article GET IT
Times cited: 5
Initial antimicrobial management of sepsis. Critical care (London, England). 2021 Information Resource GET IT
Times cited: 162
Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 2021 Academic Article GET IT
Times cited: 37
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges. Current opinion in pulmonary medicine. 2021 Information Resource GET IT
Times cited: 3
Predictive Performance of Risk Factors for Multidrug-Resistant Pathogens in Nosocomial Pneumonia. Annals of the American Thoracic Society. 2021 Academic Article GET IT
Times cited: 15
Pneumonia. Nature reviews. Disease primers. 2021 Information Resource GET IT
Times cited: 612
How low can we go in community-acquired pneumonia therapy?. Lancet (London, England). 2021 Article GET IT
Times cited: 7
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature. Expert review of vaccines. 2021 Information Resource GET IT
Times cited: 16
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence. Expert review of vaccines. 2021 Information Resource GET IT
Times cited: 52
Antibiotic Use in Sepsis: How and Why Less Can Really Mean More (Survival). American journal of respiratory and critical care medicine. 2021 Editorial Article GET IT
Times cited: 4
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). European respiratory review : an official journal of the European Respiratory Society. 2020 Information Resource GET IT
Times cited: 94
Updates on community acquired pneumonia management in the ICU. Pharmacology & therapeutics. 2020 Information Resource GET IT
Times cited: 150
Letter from the United States: A New York experience with COVID-19. Respirology (Carlton, Vic.). 2020 Article GET IT
Times cited: 1
The INHALE trial: multiple reasons for a negative result - Authors' reply. The Lancet. Infectious diseases. 2020 Article GET IT
Times cited: 2
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. Chest. 2020 Information Resource GET IT
Times cited: 211
Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM. Annals of the American Thoracic Society. 2020 Academic Article GET IT
Times cited: 87
Editorial: The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. Current opinion in pulmonary medicine. 2020 Information Resource GET IT
Times cited: 41
Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for Research. American journal of respiratory and critical care medicine. 2020 Editorial Article GET IT
Times cited: 38
The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States. Chest. 2020 Academic Article GET IT
Times cited: 102
Natural enemy or friend? Pneumonia in the very elderly critically ill patient. European respiratory review : an official journal of the European Respiratory Society. 2020 Editorial Article GET IT
Times cited: 4
25th International Symposium on Infections in the Critically Ill Patient. Medical sciences (Basel, Switzerland). 2020 Conference Paper GET IT
Times cited: 3
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial. The Lancet. Infectious diseases. 2019 Academic Article GET IT
Times cited: 107
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study. International journal of antimicrobial agents. 2019 Academic Article GET IT
Times cited: 18
Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia. Journal of clinical medicine. 2019 Academic Article GET IT
Times cited: 10
Update in Lung Infections and Tuberculosis 2018. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 1
Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials. Infectious diseases and therapy. 2019 Academic Article GET IT
Times cited: 4
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2019 Academic Article GET IT
Times cited: 36
Clinical Impact of Antimicrobial Resistance: Using New Tools to Answer Old Questions. Chest. 2019 Editorial Article GET IT
Times cited: 3
Aspiration Pneumonia. Reply. The New England journal of medicine. 2019 Article GET IT
Times cited: 4
Adjunctive Nebulized Antibiotics: What Is Their Place in ICU Infections?. Frontiers in medicine. 2019 Information Resource GET IT
Times cited: 24
Editorial: Toward improving the diagnosis, treatment and prevention of community acquired and nosocomial respiratory tract infections. Current opinion in pulmonary medicine. 2019 Editorial Article GET IT
Times cited: 3
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Academic Article GET IT
Times cited: 51
Aspiration Pneumonia. The New England journal of medicine. 2019 Information Resource GET IT
Times cited: 526
24th International Symposium on Infections in the Critically Ill Patient. Medical sciences (Basel, Switzerland). 2019 Academic Article GET IT
Times cited: 1
Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive care medicine. 2019 Information Resource GET IT
Times cited: 151
Respiratory Infections: An Ongoing Challenge with a Promising Future. Clinics in chest medicine. 2018 Editorial Article GET IT
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia. Chest. 2018 Academic Article GET IT
Times cited: 42
Beat around the bush for VA-LRTI. Intensive care medicine. 2018 Editorial Article GET IT
Times cited: 1
Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?. Current opinion in critical care. 2018 Information Resource GET IT
Times cited: 11
Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study. Pneumonia (Nathan Qld.). 2018 Academic Article GET IT
Times cited: 436
Future Research Directions in Pneumonia. NHLBI Working Group Report. American journal of respiratory and critical care medicine. 2018 Academic Article GET IT
Times cited: 75
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia. ERJ open research. 2018 Academic Article GET IT
Times cited: 57
Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU. American journal of respiratory and critical care medicine. 2018 Article GET IT
Times cited: 55
Imaging for the Management of Community-Acquired Pneumonia: What to Do if the Chest Radiograph Is Clear. Chest. 2018 Editorial Article GET IT
Times cited: 9
23rd International Symposium on Infections in the Critically Ill Patient. Medical sciences (Basel, Switzerland). 2018 Conference Paper GET IT
Times cited: 1
Pneumonia Complicating COPD: Are Corticosteroids a Help or a Hindrance?. Chronic obstructive pulmonary diseases (Miami, Fla.). 2018 Academic Article GET IT
Times cited: 2
Adjuvant therapies in critical care: steroids in community-acquired pneumonia. Intensive care medicine. 2017 Article GET IT
Times cited: 12
Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome. Medicina intensiva. 2017 Academic Article GET IT
Times cited: 34
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). The European respiratory journal. 2017 Information Resource GET IT
Times cited: 1111
Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia. Intensive care medicine. 2017 Academic Article GET IT
Times cited: 45
Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial. PloS one. 2017 Academic Article GET IT
Times cited: 26
Using Ventilator-Associated Pneumonia Rates as a Health Care Quality Indicator: A Contentious Concept. Seminars in respiratory and critical care medicine. 2017 Information Resource GET IT
Times cited: 10
The research agenda in VAP/HAP: next steps. Intensive care medicine. 2017 Academic Article GET IT
Times cited: 10
Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia. The Journal of infection. 2017 Academic Article GET IT
Times cited: 9
Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia. Chest. 2017 Academic Article GET IT
Times cited: 16
Principles of Antibiotic Management of Community-Acquired Pneumonia. Seminars in respiratory and critical care medicine. 2016 Information Resource GET IT
Times cited: 5
Serum procalcitonin and the admission decision in CAP. The Lancet. Respiratory medicine. 2016 Article GET IT
Times cited: 2
The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia. Annals of the American Thoracic Society. 2016 Academic Article GET IT
Times cited: 95
Community-acquired pneumonia related to intracellular pathogens. Intensive care medicine. 2016 Information Resource GET IT
Times cited: 113
Lessons learned from 2 decades of CAP therapy data: ways to improve patient management. Journal of thoracic disease. 2016 Article GET IT
Times cited: 2
Improving outcomes in community-acquired pneumonia. Current opinion in pulmonary medicine. 2016 Information Resource GET IT
Times cited: 11
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia. The European respiratory journal. 2016 Article GET IT
Times cited: 20
Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa. Chest. 2016 Academic Article GET IT
Times cited: 105
What is Legionnaires' Disease?. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Outcomes and Prognostic Features of Patients With Influenza Requiring Hospitalization and Receiving Early Antiviral Therapy: A Prospective Multicenter Cohort Study. Chest. 2016 Academic Article GET IT
Times cited: 41
The road forward in the management of Acinetobacter infections in the ICU. Intensive care medicine. 2015 Editorial Article GET IT
Times cited: 3
Bacteraemia in outpatients with community-acquired pneumonia. The European respiratory journal. 2015 Article GET IT
Times cited: 7
In the Clinic: Community-Acquired Pneumonia. Annals of internal medicine. 2015 Information Resource GET IT
Times cited: 18
Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study. BMC pulmonary medicine. 2015 Academic Article GET IT
Times cited: 8
Respiratory tract infections in community and healthcare settings: epidemiological, diagnostic and management challenges. Current opinion in pulmonary medicine. 2015 Editorial Article GET IT
Times cited: 3
Ventilator-associated pneumonia prevention: response to Silvestri et al. Intensive care medicine. 2015 Article GET IT
Times cited: 1
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis. The European respiratory journal. 2015 Academic Article GET IT
Times cited: 48
Year in review 2013: Critical Care--respiratory infections. Critical care (London, England). 2014 Information Resource GET IT
Times cited: 11
An Economic Model to Compare the Different Empiric and First/Second Line Treatment Regimens for Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014 Academic Article GET IT
Reply to Yamamoto et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014 Article GET IT
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Academic Article GET IT
Times cited: 111
Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Critical care medicine. 2013 Academic Article GET IT
Times cited: 65
Is a strategy based on routine endotracheal cultures the best way to prescribe antibiotics in ventilator-associated pneumonia?. Chest. 2013 Academic Article GET IT
Times cited: 38
Preparing for the unexpected: lessons learned about respiratory infection from the Japanese tsunami of 2011. Chest. 2013 Editorial Article GET IT
Times cited: 1
Acute lower respiratory infections in developing countries. Lancet (London, England). 2013 Article GET IT
Times cited: 24
Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive care medicine. 2013 Academic Article GET IT
Times cited: 133
The Barcelona Declaration from the World Alliance against Antibiotic Resistance: engagement of intensivists. Critical care (London, England). 2012 Editorial Article GET IT
Times cited: 5
Update in respiratory infections 2011. American journal of respiratory and critical care medicine. 2012 Information Resource GET IT
Times cited: 2
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Academic Article GET IT
Times cited: 508
BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia. Intensive care medicine. 2011 Academic Article GET IT
Times cited: 147
Treatment of hospital-acquired pneumonia. The Lancet. Infectious diseases. 2011 Article GET IT
Times cited: 7
Respiratory tract infections: advances in diagnosis, management and prevention. Clinics in chest medicine. 2011 Editorial Article GET IT
Management of pneumonia in the nursing home. Chest. 2010 Information Resource GET IT
Times cited: 22
Nursing home-acquired pneumonia: a review of risk factors and therapeutic approaches. Current medical research and opinion. 2010 Information Resource GET IT
Times cited: 36
Assessment of risk factors for multi-drug resistant organisms to guide empiric antibiotic selection in long term care: a dilemma. Journal of the American Medical Directors Association. 2010 Editorial Article GET IT
Times cited: 25
Management of community-acquired pneumonia: a review and update. Therapeutic advances in respiratory disease. 2010 Information Resource GET IT
Times cited: 48
Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Information Resource GET IT
Times cited: 73
The argument against using quantitative cultures in clinical trials and for the management of ventilator-associated pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Information Resource GET IT
Times cited: 42
Year in review 2009: Respiratory infections, tuberculosis, pleural diseases and lung cancer. Respirology (Carlton, Vic.). 2010 Information Resource GET IT
Times cited: 1
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ (Clinical research ed.). 2010 Academic Article GET IT
Times cited: 252
Fluoroquinolones in the management of community-acquired pneumonia. International journal of clinical practice. 2010 Information Resource GET IT
Times cited: 29
Is lifelong anticoagulation worth the risk in patients with unprovoked DVT?. Annals of internal medicine. 2009 Article GET IT
Pneumonia severity index Class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. 2007. Chest. 2009 Article
In the clinic. Community-acquired pneumonia. Annals of internal medicine. 2009 Information Resource GET IT
Times cited: 9
Cardiovascular biomarkers in the ICU. Current opinion in critical care. 2009 Information Resource GET IT
Times cited: 18
Road ahead to respiratory health: experts chart future research directions. Respirology (Carlton, Vic.). 2009 Information Resource GET IT
Times cited: 12
Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Academic Article GET IT
Times cited: 153
Standardized care for nosocomial pneumonia is a valuable tool to improve patient outcomes: how do we get intensivists to listen?. Critical care medicine. 2009 Editorial Article GET IT
Times cited: 3
Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Information Resource GET IT
Times cited: 56
Guideline tyranny: a response to the article by Baum and Kaltsas. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Article GET IT
Times cited: 2
A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respiratory medicine. 2008 Academic Article GET IT
Times cited: 74
How can we improve the management and outcome of pneumonia in the elderly?. The European respiratory journal. 2008 Editorial Article GET IT
Times cited: 11
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome. The European respiratory journal. 2008 Academic Article GET IT
Times cited: 81
Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Academic Article GET IT
Times cited: 111
Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury. Chest. 2008 Academic Article GET IT
Times cited: 55
Markers of treatment failure in hospitalised community acquired pneumonia. Thorax. 2008 Academic Article GET IT
Times cited: 167
The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Archives of internal medicine. 2007 Academic Article GET IT
Times cited: 50
A prediction model for bacterial etiology in acute exacerbations of COPD. Infection. 2007 Academic Article GET IT
Times cited: 65
Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infection control and hospital epidemiology. 2007 Academic Article GET IT
Times cited: 161
Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest. 2007 Academic Article GET IT
Times cited: 110
Hyponatremia in community-acquired pneumonia. American journal of nephrology. 2007 Academic Article GET IT
Times cited: 123
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006 Academic Article GET IT
Times cited: 265
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. Respiratory medicine. 2006 Academic Article GET IT
Times cited: 24
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. The European respiratory journal. 2006 Academic Article GET IT
Times cited: 225
Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. The European respiratory journal. 2006 Editorial Article GET IT
Times cited: 58
Health-care-associated pneumonia: a new therapeutic paradigm. Chest. 2005 Editorial Article GET IT
Times cited: 27
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 Academic Article GET IT
Times cited: 90
Review of treatment guidelines for community-acquired pneumonia. The American journal of medicine. 2004 Information Resource GET IT
Times cited: 33
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials. Current medical research and opinion. 2004 Academic Article GET IT
Times cited: 16
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin. Current medical research and opinion. 2004 Academic Article GET IT
Times cited: 14
Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax. 2004 Academic Article GET IT
Times cited: 215
A Retrospective Evaluation of Fluoroquinolone Antibacterial Selection in a U.S. Community Hospital. Today's Therapeutic Trends. 2004 Article
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. Treatments in respiratory medicine. 2004 Academic Article GET IT
Times cited: 53
[Conservative use of antibiotics is important, but: "Resistance hysteria is exaggerated"]. MMW Fortschritte der Medizin. 2003 Article GET IT
Diagnosis and treatment of rhinovirus respiratory infections. Chest. 2003 Information Resource GET IT
Times cited: 44
Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia. Critical care medicine. 2003 Academic Article GET IT
Times cited: 29
Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Critical care medicine. 2003 Academic Article GET IT
Times cited: 436
Appropriate use of antimicrobial agents: challenges and strategies for improvement. Critical care medicine. 2003 Information Resource GET IT
Times cited: 104
Granulocyte colony-stimulating factor for severe pneumonia: what do we do when the best laid plans for men (and mice and rats...) fail?. Critical care medicine. 2003 Editorial Article GET IT
Times cited: 2
How do we achieve adequate therapy for severe infection?. Critical care medicine. 2003 Editorial Article GET IT
Times cited: 8
Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. Journal of intensive care medicine. 2003 Information Resource GET IT
Times cited: 46
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002 Information Resource GET IT
Times cited: 203
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia. Chest. 2002 Academic Article GET IT
Times cited: 37
Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Archives of internal medicine. 2002 Academic Article GET IT
Times cited: 352
The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. Archives of internal medicine. 2002 Academic Article GET IT
Times cited: 81
Can optimal management prevent mortality in ventilator-associated pneumonia?. Critical care medicine. 2002 Editorial Article GET IT
Times cited: 11
How do we optimize outcomes for patients with severe community-acquired pneumonia?. Intensive care medicine. 2002 Editorial Article GET IT
Times cited: 10
Nosocomial pneumonia. Current opinion in infectious diseases. 2002 Information Resource GET IT
Times cited: 20
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?. The European respiratory journal. 2002 Information Resource GET IT
Times cited: 23
Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002 Academic Article GET IT
Times cited: 132
Pneumonia treatment process and quality. Archives of internal medicine. 2002 Article GET IT
Times cited: 14
Acute exacerbations of chronic obstructive pulmonary disease. Annals of internal medicine. 2002 Article GET IT
Times cited: 1
Community-acquired pneumonia: Management controversies, part 1. Journal of Respiratory Diseases. 2002 Article
Can guidelines for the treatment of respiratory infections lead to reduced rates of antibiotic resistance?. Seminars in respiratory infections. 2001 Information Resource GET IT
Times cited: 7
Cost effectiveness in treating ventilator-associated pneumonia. Critical care (London, England). 2001 Academic Article GET IT
Times cited: 5
Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia. Chest. 2001 Academic Article GET IT
Times cited: 73
Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states : 1993, 1995, and 1997. Chest. 2001 Academic Article GET IT
Times cited: 188
Antimicrobial resistance in the ICU: The time for action is now. Critical care medicine. 2001 Academic Article GET IT
Times cited: 10
Impact of antibiotic resistance on clinical outcomes and the cost of care. Critical care medicine. 2001 Information Resource GET IT
Times cited: 155
Bacteria and COPD exacerbations redux. Chest. 2001 Article GET IT
Times cited: 7
Management of suspected ventilator-associated pneumonia. Annals of internal medicine. 2000 Article GET IT
Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000 Information Resource GET IT
Times cited: 646
Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 2000 Academic Article GET IT
Times cited: 40
Adequate empirical therapy minimizes the impact of diagnostic methods in patients with ventilator-associated pneumonia. Critical care medicine. 2000 Editorial Article GET IT
Times cited: 15
The role of bacteria in exacerbations of COPD. A constructive view. Chest. 2000 Article GET IT
Times cited: 112
Differential patterns of apoptosis in resolving and nonresolving bacterial pneumonia. American journal of respiratory and critical care medicine. 2000 Academic Article GET IT
Times cited: 23
Bronchoscopy in nonresolving nosocomial pneumonia. Chest. 2000 Information Resource GET IT
Times cited: 20
Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest. 2000 Academic Article GET IT
Times cited: 221
Antibiotic therapy of exacerbations of chronic bronchitis. Seminars in respiratory infections. 2000 Information Resource GET IT
Times cited: 45
Why can't I see clearly now? I have a meta-analysis!. Critical care medicine. 1999 Editorial Article GET IT
Times cited: 4
Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia. Chest. 1999 Academic Article GET IT
Times cited: 106
Inflammation in severe pneumonia: act locally, not globally. Critical care medicine. 1999 Editorial Article GET IT
Times cited: 9
HIV disease, persistent fever, nonresolving pneumonia, tuberculosis. Patient Care. 1999 Article
Treatment cost of acute exacerbations of chronic bronchitis. Clinical therapeutics. 1999 Academic Article GET IT
Times cited: 149
[Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis]. Medicina. 1999 Academic Article GET IT
Times cited: 3
Community-Acquired Pneumonia: Defining the problem. Infections in Medicine. 1998 Article
Respiratory Infection in the Critically Ill: Mechanisms and the Role of Apoptosis in the Response to Infection. Sepsis. 1998 Article
Community-acquired pneumonia. Disease-a-month : DM. 1998 Information Resource GET IT
Times cited: 25
Severe community-acquired pneumonia. Assessment of severity criteria. American journal of respiratory and critical care medicine. 1998 Academic Article GET IT
Times cited: 321
Role of quinolones in treatment of pneumonia and acute exacerbations of chronic bronchitis. Infectious Diseases in Clinical Practice. 1998 Article
Empirical therapy for community-acquired pneumonia. Annals of internal medicine. 1998 Article GET IT
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest. 1998 Academic Article GET IT
Times cited: 389
A "closed" medical intensive care unit (MICU) improves resource utilization when compared with an "open" MICU. American journal of respiratory and critical care medicine. 1998 Academic Article GET IT
Times cited: 230
Introduction: mechanisms and management of COPD: we can do better--it's time for a re-evaluation. Chest. 1998 Academic Article GET IT
Community-acquired pneumonia: a North American perspective. Chest. 1998 Academic Article GET IT
Times cited: 18
Strategies for prevention of community-acquired pneumonia. Seminars in respiratory infections. 1998 Information Resource GET IT
Times cited: 4
Bronchoscopy for ventilator-associated pneumonia: show me the money (outcome benefit)!. Critical care medicine. 1998 Editorial Article GET IT
Times cited: 17
Update in pulmonary medicine. Annals of internal medicine. 1998 Information Resource GET IT
Times cited: 13
Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. Clinical therapeutics. 1998 Academic Article GET IT
Times cited: 75
The cost of treating community-acquired pneumonia. Clinical therapeutics. 1998 Academic Article GET IT
Times cited: 506
Introduction: COPD--the role of infection. Chest. 1997 Academic Article GET IT
Times cited: 17
Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Critical care medicine. 1997 Academic Article GET IT
Times cited: 188
Evidence based medicine in critical care: will it take us over the cutting edge?. Critical care medicine. 1997 Editorial Article GET IT
Times cited: 4
Devising strategies for preventing nosocomial pneumonia--should we ignore the stomach?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1997 Editorial Article GET IT
Times cited: 44
Treatment of hospital-acquired pneumonia. Seminars in Respiratory and Critical Care Medicine. 1997 Article
Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group. Clinical therapeutics. 1997 Academic Article GET IT
Times cited: 21
[Community-acquired pneumonia in adults. Clinical practice guideline for Argentina. Study Group on Community Acquired Pneumonia]. Medicina. 1997 Information Resource GET IT
Times cited: 17
Clinical pathways in an acute care setting: Community-acquired pneumonia. Infectious Diseases in Clinical Practice. 1996 Article
Diagnosis and treatment of nosocomial pneumonia. Current Opinion in Critical Care. 1996 Article
Health outcomes in infectious diseases: A clinician's perspective of pneumonia management. Infections in Medicine. 1996 Article
Hospitalized patients with community-acquired pneumonia: Overview of ats guidelines and initial management. Infectious Diseases in Clinical Practice. 1996 Article
Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1996 Academic Article GET IT
Times cited: 168
Apoptosis and the histologic stage of pneumonia: Does the severity of pneumonia correlate with the apoptosis index?. Chest. 1996 Article
Systemic inflammatory response syndrome in patients with and without cardiac disease. Chest. 1996 Article
Clostridium difficile infection as a cause of severe sepsis. Intensive care medicine. 1996 Article GET IT
Times cited: 28
Guidelines for the management of respiratory infection: why do we need them, how should they be developed, and can they be useful?. Current opinion in pulmonary medicine. 1996 Editorial Article GET IT
Times cited: 32
Community-acquired pneumonia. The New England journal of medicine. 1996 Article GET IT
Times cited: 1
New etiopathogenic concepts of ventilator-associated pneumonia. Seminars in respiratory infections. 1996 Information Resource GET IT
Times cited: 10
Acute bronchitis in adults and children. Patient Care. 1996 Article
When chronic bronchitis turns acute. Patient Care. 1996 Article
Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster?. American journal of respiratory and critical care medicine. 1995 Academic Article GET IT
Times cited: 52
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Critical care medicine. 1995 Academic Article GET IT
Times cited: 299
New approaches to prevention and treatment of nosocomial pneumonia. Seminars in thoracic and cardiovascular surgery. 1995 Information Resource GET IT
Times cited: 9
Questionable susceptibility reporting in a multicenter trial. Antimicrobial agents and chemotherapy. 1995 Article GET IT
An antimicrobial approach to nosocomial pneumonia. Contemporary internal medicine. 1995 Information Resource GET IT
Times cited: 2
Prevention of ventilator-associated pneumonia. An attainable goal?. Clinics in chest medicine. 1995 Information Resource GET IT
Times cited: 13
Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin. Drugs. 1995 Academic Article GET IT
Times cited: 6
The pathogenesis of airway colonization: lessons learned from the study of bacterial adherence. The European respiratory journal. 1994 Editorial Article GET IT
Times cited: 39
An approach to empiric therapy of nosocomial pneumonia. The Medical clinics of North America. 1994 Information Resource GET IT
Times cited: 41
Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. American journal of respiratory and critical care medicine. 1994 Academic Article GET IT
Times cited: 235
Treatment of severe pneumonia with ciprofloxacin or imipenem. Antimicrobial agents and chemotherapy. 1994 Article GET IT
Times cited: 2
Predicting bacteremia in critically ill patients: a clinically relevant effort?. Intensive care medicine. 1994 Editorial Article GET IT
Times cited: 5
Response to "Treatment guidelines for nosocomial pneumonia: Agreeing to disagree". The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 1994 Article GET IT
Benefits of a multidisciplinary pulmonary rehabilitation program. Chest. 1994 Article GET IT
Times cited: 2
Severe pneumonia in the elderly. Clinics in geriatric medicine. 1994 Information Resource GET IT
Times cited: 36
Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 1993 Academic Article GET IT
Nonresolving and slowly resolving pneumonia. Diagnosis and management in the elderly patient. Clinics in chest medicine. 1993 Information Resource GET IT
Times cited: 25
Nosocomial pneumonia in the elderly patient. Chronic care facility and hospital considerations. Clinics in chest medicine. 1993 Information Resource GET IT
Times cited: 32
Antimicrobial treatment of community acquired pneumonia in adults: A conference report. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 1993 Academic Article GET IT
Noninfectious respiratory disease in pregnancy. Cleveland Clinic journal of medicine. 1993 Article GET IT
Times cited: 4
Definition and evaluation of the resolution of nosocomial pneumonia. Seminars in respiratory infections. 1992 Information Resource GET IT
Times cited: 22
Pneumonia complicating pregnancy. Clinics in chest medicine. 1992 Information Resource GET IT
Times cited: 63
The application of decision analysis to critical care medicine. Intensive care world. 1992 Information Resource GET IT
Times cited: 3
Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. The American journal of medicine. 1992 Academic Article GET IT
Times cited: 74
Rapidly progressive respiratory failure due to Aspergillus pneumonia: a complication of short-term corticosteroid therapy. Critical care medicine. 1992 Article GET IT
Times cited: 23
Characterization of Pseudomonas aeruginosa adherence to cultured hamster tracheal epithelial cells. American journal of respiratory cell and molecular biology. 1991 Academic Article GET IT
Times cited: 16
Delivery of topical antibiotics: pharmacokinetics and clinical problems. Seminars in respiratory infections. 1991 Information Resource GET IT
Times cited: 14
The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia. Clinics in chest medicine. 1991 Information Resource GET IT
Times cited: 126
Atypical manifestations of pneumonia in the elderly. Clinics in chest medicine. 1991 Information Resource GET IT
Times cited: 49
Neutrophil-endothelial cell interaction in critical illness. Chest. 1991 Academic Article GET IT
Times cited: 18
Benefits of a multidisciplinary pulmonary rehabilitation program. Improvements are independent of lung function. Chest. 1991 Academic Article GET IT
Times cited: 147
Diagnosing nosocomial pneumonia: to brush or not to brush. Journal of intensive care medicine. 1991 Editorial Article GET IT
Times cited: 4
Impact of anaesthetic procedures on colonization defences of the tracheobronchial tree. Bailliere's Clinical Anaesthesiology. 1991 Article GET IT
Sepsis syndrome. Infectious Diseases Newsletter. 1991 Article GET IT
Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia. A common clinical sequence. Clinics in chest medicine. 1990 Information Resource GET IT
Times cited: 95
Utility of fiberoptic bronchoscopy in nonresolving pneumonia. Chest. 1990 Academic Article GET IT
Times cited: 118
Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences. Seminars in respiratory infections. 1990 Information Resource GET IT
Times cited: 94
Pneumonia in the critically ill hospitalized patient. Chest. 1990 Article GET IT
Times cited: 58
Respiratory infections and acute lung injury in systemic illness. Clinics in chest medicine. 1989 Information Resource GET IT
Times cited: 32
Bacterial adherence as a mechanism of airway colonization. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 1989 Information Resource GET IT
Times cited: 28
Patterns and routes of tracheobronchial colonization in mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest. 1989 Academic Article GET IT
Times cited: 128
Pulmonary edema with low pulmonary capillary wedge pressure after acute myocardial infarction: Clinical features and prognostic implications. Journal of Critical Care. 1989 Article GET IT
Non-cardiogenic pulmonary edema after pericardial drainage for cardiac tamponade. Chest. 1988 Article GET IT
Times cited: 15
"When the pneumonia doesn't get better". Clinics in chest medicine. 1987 Information Resource GET IT
Times cited: 32
Strategies for the prevention of pneumonia. Clinics in chest medicine. 1987 Information Resource GET IT
Times cited: 7
Reversal of sleep apnea in uremia by dialysis. Archives of internal medicine. 1987 Article GET IT
Times cited: 59
New infiltrate following motor vehicle accident. Chest. 1987 Article GET IT
Times cited: 1
Cardiovascular function in secondary pulmonary hypertension. Heart & lung : the journal of critical care. 1986 Information Resource GET IT
Times cited: 19
Pathophysiology of the adult respiratory distress syndrome. What have we learned from human studies?. Critical care clinics. 1986 Information Resource GET IT
Times cited: 24
Bacterial adherence to respiratory tract cells. Relationships between in vivo and in vitro pH and bacterial attachment. The American review of respiratory disease. 1986 Academic Article GET IT
Times cited: 32
Pneumonia in the elderly. Clinics in geriatric medicine. 1986 Information Resource GET IT
Times cited: 62
Considerations in the management of patients with asthma and hypertension. Practical Cardiology. 1986 Article
Nosocomial pulmonary infections in acute respiratory failure. Respiratory Care. 1983 Article

more ...

less ...

Background

education and training

A.B., Boston University 1977
M.D., Boston University School of Medicine 1977

Contact

full name

Michael S. Niederman

primary email

msn9004@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Michael S. Niederman Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage